Exicure, Inc. Files 8-K Report

TL;DR

EXICURE FILES 8-K - NO SPECIFIC DETAILS YET.

AI Summary

On December 17, 2024, Exicure, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and does not detail specific transactions, financial figures, or new agreements within the provided text. The report confirms Exicure, Inc. as the registrant, incorporated in Delaware with its principal executive offices in Chicago, IL.

Why It Matters

This filing indicates a routine update or event disclosure by Exicure, Inc. to the SEC, which is important for investors to monitor for any material changes in the company's status.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report without immediate disclosed material events, suggesting low immediate risk based on this document alone.

Key Players & Entities

• EXICURE, INC. (company) — Registrant
• December 17, 2024 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• Chicago, IL (location) — Principal Executive Offices
• Max-1 Acquisition Corp (company) — Former Company Name

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock, par value $0.0001 per share XCUR The Nasdaq Stock Market
• $2.5 million — Company no longer satisfied the minimum $2.5 million stockholders' equity requirement for co
• $2.2 million — ders' deficit as of March 31, 2024, was $2.2 million. The Company thereafter presented its p
• $3.00 — y's common stock at a purchase price of $3.00 per share (the "Initial Purchase"). The
• $1.3 million — nd the Company received net proceeds of $1.3 million. On November 13, 2024, in a subsequent
• $8.7 m — the Initial Shares, the "Shares"), for $8.7 million, at a purchase price of $3.00 per
• $4.61 — y's common stock at a purchase price of $4.61 per share, which closed on December 12,
• $2 million — received net proceeds of approximately $2 million. As set forth in the pro forma balance
• $4.3 million — he date of this filing is approximately $4.3 million. The Company awaits Nasdaq's confirmati

Filing Documents

• xcur-20241217.htm (8-K) — 31KB
• a8k121724exhibit991.htm (EX-99.1) — 29KB
• 0001698530-24-000139.txt ( ) — 184KB
• xcur-20241217.xsd (EX-101.SCH) — 2KB
• xcur-20241217_lab.xml (EX-101.LAB) — 21KB
• xcur-20241217_pre.xml (EX-101.PRE) — 12KB
• xcur-20241217_htm.xml (XML) — 3KB

01 Other Events

Item 8.01 Other Events. As previously disclosed, on June 20, 2024, Exicure Inc. (the "Company") was notified by The Nasdaq Stock Market LLC ("Nasdaq") that the Company no longer satisfied the minimum $2.5 million stockholders' equity requirement for continued listing on The Nasdaq Capital Market (the "Equity Requirement"). The Company's stockholders' deficit as of March 31, 2024, was $2.2 million. The Company thereafter presented its plan to regain compliance with the Equity Requirement to a Nasdaq Hearings Panel (the "Panel"), subsequent to which the Panel ultimately granted the Company an extension through December 17, 2024 to do so. In its effort to regain compliance with the Equity Requirement, the Company has completed the following transactions: On November 12, 2024, the Company executed a common stock purchase agreement with HiTron Systems Inc. ("HiTron"), pursuant to which the Company agreed to issue and sell to HiTron 433,000 shares (the "Initial Shares") of the Company's common stock at a purchase price of $3.00 per share (the "Initial Purchase"). The Initial Purchase closed on November 21, 2024, and the Company received net proceeds of $1.3 million. On November 13, 2024, in a subsequent common stock purchase agreement, the Company agreed to sell and issue to HiTron 2,900,000 additional shares of common stock (the "Subsequent Shares" and together with the Initial Shares, the "Shares"), for $8.7 million, at a purchase price of $3.00 per share (the "Subsequent Purchase"). The issuance of the Subsequent Shares was approved by the Company's stockholders at a special shareholder meeting on December 17, 2024. On December 9, 2024, the Company executed a common stock purchase agreement with SangSangIn Investment & Securities Co., Ltd. ("SangSang"), pursuant to which the Company agreed to issue and sell to SangSang 433,332 shares of the Company's common stock at a purchase price of $4.61 per share, which closed on December 12, 2024. The Company received net pr

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains certain forward-looking statements within the meaning of the federal securities laws with respect to the Company and the Share Repurchase Program. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties that could cause the actual results to differ materially from the expected results. As a result, caution must be exercised in relying on forward-looking statements, which speak only as of the date they were made. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of other risks and uncertainties, and other important factors, any of which could cause the Company's actual results to differ from those contained in the forward-looking statements, see the section titled "Risk Factors" in the Company's Annual Report on Form 10-K filed with the SEC for the year ended December 31, 2023, as updated by the Company's subsequent reports and filings with the Securities and Exchange Commission. All information in this Current Report on Form 8-K is as of the date of the filing hereof, and the Company undertakes no duty to update this information or to publicly announce the results of any revisions to any of such statements to reflect future events or developments, except as required by law.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Pro Forma Balance Sheet, dated December 17, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 17, 2024 EXICURE, INC. By: /s/ Paul Kang Paul Kang Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR